 |
| september
3, 2025 |
| Covering
Life Sciences Drugs, Diagnostics, Devices,
Digital Health |
|
|
|
* may need subscription to view |
 |
 |
| Boston's
most flexible contract vivarium
lab space: Start with a few study
cages and grow. |
|
Learn More
→ |
|
|
- Charles River: Enhances Cell Therapy
Flex Platform Through Collaboration With
Akadeum Life Sciences More
- Eisai: Initiated Rolling Supplemental
Biologics License Application to the U.S. FDA
for LEQEMBI IQLIK (lecanemab-irmb) as a
Subcutaneous Starting Dose for the Treatment
of Early Alzheimer's Disease Under Fast Track
Status More
- Enanta Pharmaceuticals: Passing of Its
Beloved and Respected Longtime Chief
Financial and Administrative Officer Paul J.
Mellett Jr. More
- enGene: Achieves Target Enrollment Milestone
for LEGEND Trial Pivotal Cohort More
- Enveric Biosciences: Relocates Corporate
Headquarters to Cambridge, MA More
- Hemab Therapeutics: Expands Leadership With
Appointment of Anant Murthy, PhD, as Chief
Operating Officer More
- Kymera Therapeutics: Appoints Brian Adams
as Chief Legal Officer and Corporate
Secretary More
- Parabilis Medicines: Appoints Fawzi
Benzaghou, M.D., as Chief Medical Officer More
- Pretzel Therapeutics: Strengthens
Leadership With Appointment of Ashish Dugar,
Ph.D., MBA as Chief Development Officer More
- ProMIS Neurosciences: Receives DSMB Approval
to Advance to Final Dose Escalation Cohort in
Phase 1b Alzheimer’s Trial of PMN310 More
- Stratus: Nobel Laureate Dr. Ardem
Patapoutian Joins Scientific Advisory Board More
- TOBY: Appoints Healthcare Leader Matthew
Collier as Independent Director More
- Wave Life Sciences: Positive Update From
Ongoing RestorAATion-2 Trial of WVE-006 in
Alpha-1 Antitrypsin Deficiency More
More*
|
|
 |
 |
| Big4Bio
podcast talked to Kevin Sarney,
about the current uncertainty
biotechs face, the need for
capital efficiency, and how
companies can best prepare for
future opportunities. |
|
Learn More
→ |
|
|
|
- Argo Biopharma: Multi-Asset License and
Option Agreements With Novartis for Novel
Molecules for Cardiovascular Diseases More
- Bruker: Public Offering of $600 Million of
Mandatory Convertible Preferred Stock More
- Entrada Therapeutics: Inducement Grants
Under Nasdaq Listing Rule 5635(c)(4) More
- Get Discounted Access to Exclusive
Biotech Intelligence from BYTE51 More
- More on Royalty Bestowing Zenas With $300M
Deal to Push Autoimmune Asset Across FDA
Finish Line More
- More on Startup Corsera Health Aiming to
Bring Preventive Heart Medicine to the Masses
More
- The Big4Bio Podcast: Surviving and
Thriving in the Long Biotech Winter Podcast
- Treeline:
First Clinical Trials and Secures $200M in
Additional Funding More
- Vertex Locks on to $2B Covalent Biologics
Deal With Enlaza More
More
More
More*
|
|
 |
|
- After Strategic Pivot, Editas Lays Out Plan
to Target High Cholesterol With Gene Editing More
More*
- More on Upstream Bio’s Phase 2 Win Setting
It Up as a Potential Dupixent, Tezspire
Competitor More*
- Subscribe to LifeSci Startup for
Updates on US Startups More
|
|
|
DISCOVER COMPANIES |
|
Big4Bio: Boston Life Science
Company Directory |
|
Locate a specific company or
explore new companies in life
science. |
|
Explore
our Company Directory
|
Provided courtesy
of
 |
|
|
|
Feature your company |
| Apply
to have your company
showcased by Big4Bio |
|
|
|
|
|
 |
|
Premier Executive Search and
Talent Advisory Firm Slone
Partners Launches Fractional
Talent Service to Deliver
On-Demand Leaders and Specialists
|
|
Learn More
→ |
|
|
- FEATURE: The Power of Peer Learning:
Why Even Top Biotech Leaders Need Mentorship
More
- ICYMI: The Changing Landscape of Diagnostics
More
- ICYMI: CEO's Perspective: The Power of
Pivoting More
- ICYMI: What Defines Great Leadership? More
- Lilly Neuro Exec Anne White to Retire;
Bristol Myers Fills New Medical Affairs
Position More*
- Organizational Leader and Business
Strategist Kyle Kinzie Named President &
Partner More
|
|
 |
Event
Center
|
Note:
Events may be in any Big4Bio region or
virtual |
|
- Grant Engine Webinar - Mastering Funding in
2025 Sept
3
- Hub and Specialty Pharmacy Models West
(Promo Code 25B4B10 to save 10%) Sept
4-5
- PCC West Pharmaceutical Compliance Congress
Sept
4-5
- Charles River Biotech Symposium Sept
8-10
- LinkedIn Strategies for Scientists -
Chaperone Webinar Sept
9
- Philly Builds Bio+ 4th Annual Symposium for
Life Science Innovation and Development Sept
9
- AI Meets Amplification: Smarter PR
Strategies for Life Sciences Companies Sept
10
- International Life Sciences & Biotech
Conference (Discount Code BIG4BIO for 20% Off)
Sept
10–11
- CRAACO: Clinical Research as a Care
Option Sept
15
- Partnerships with Sites Sept
15
- LSX World Congress USA Sept
16-17
- 15th Annual DPHARM Sept
16-17
- Venture Catalyst - Exploring Life Sciences
VC in Los Angeles Sept
16
- RESI Boston 2025 Sept
17
- Discovery On Target Sept
22-25
- Life Sciences Future Sept
25-26
- Science to Strategy: Advanced Degrees in
Consulting Sept
25
- AI LA Life Summit 2025 (Exclusive Discount:
B1G4BAIO) Sept
27
- The MedTech Conference Oct
5-8
- Fierce Biotech Week Oct
7-9
- MedFuel/One Life Science/WOMEN IN BIO
(Discount Code: Big4Bio) Oct
9
- BioFuture Oct
13-14
- 2025 Battle of the Bio\Tech Bands West Oct
21
|
SEE FULL
EVENT SCHEDULE AT THE BIOCALENDAR
|
 |
|
|
|
You are
receiving this email because
you signed up for one of our
newsletters at Big4Bio.com,
signed up at one of our
partner or sponsor events,
or given as a gift
subscription by your firm or
organization. Unsubscribe
Big4Bio:Boston,
all rights reserved 2025
© 2025
Big4Bio, a division of
BigBio Communications. All
rights reserved.
|
|
|
|
|
